{"DataElement":{"publicId":"3669467","version":"1","preferredName":"Index Biopsy Histologic Finding Category","preferredDefinition":"Identifies the histologic findings of the index biopsy.","longName":"3238705v1.0:3669423v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3238705","version":"1","preferredName":"Index Biopsy Finding","preferredDefinition":"Index; a numerical scale used to compare variables with one another or with some reference number._Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body._Clinical manifestations that can be either objective when observed by a physician, or subjective when perceived by the patient.","longName":"IX_BX_FNG","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2821069","version":"1","preferredName":"Index","preferredDefinition":"Index; a numerical scale used to compare variables with one another or with some reference number.","longName":"C25390","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Index","conceptCode":"C25390","definition":"A numerical scale used to compare variables with one another or with some reference number; a number used to select an element of a list, vector, array or other sequence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F388A92-D772-E7A3-E040-BB89AD437348","latestVersionIndicator":"Yes","beginDate":"2008-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-12-29","modifiedBy":"ONEDATA","dateModified":"2008-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3238703","version":"1","preferredName":"Biopsy Finding","preferredDefinition":"Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.:Clinical manifestations that can be either objective when observed by a physician, or subjective when perceived by the patient.","longName":"C15189:C3367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biopsy","conceptCode":"C15189","definition":"The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A41FA3DD-95D4-2446-E040-BB89AD43483C","latestVersionIndicator":"Yes","beginDate":"2011-05-25","endDate":null,"createdBy":"MAESKEB","dateCreated":"2011-05-25","modifiedBy":"ONEDATA","dateModified":"2011-05-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A41FA3DD-95E5-2446-E040-BB89AD43483C","latestVersionIndicator":"Yes","beginDate":"2011-05-25","endDate":null,"createdBy":"MAESKEB","dateCreated":"2011-05-25","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3669423","version":"1","preferredName":"Histologic Finding Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"3669423v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Normal","valueDescription":"Normal","ValueMeaning":{"publicId":"2567281","version":"1","preferredName":"Normal","longName":"2567281","preferredDefinition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Normal","conceptCode":"C14165","definition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D3DE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-72FC-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Inflammation","valueDescription":"Inflammation","ValueMeaning":{"publicId":"2581231","version":"1","preferredName":"Inflammation","longName":"2581231","preferredDefinition":"A localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inflammation","conceptCode":"C3137","definition":"A finding of a localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A5C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-17","modifiedBy":"COOPERM","dateModified":"2019-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-7306-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Microcalcifications","valueDescription":"Microcalcification","ValueMeaning":{"publicId":"3227207","version":"1","preferredName":"Microcalcification","longName":"3227207","preferredDefinition":"Tiny deposits of calcium in tissue.  In the breast they can be seen using mammography, and if found in clusters may be indicative of breast cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Microcalcification","conceptCode":"C8433","definition":"Tiny deposits of calcium in tissue.  In the breast they can be seen using mammography, and if found in clusters may be indicative of breast cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0BF546B-322C-4770-E040-BB89AD437248","latestVersionIndicator":"Yes","beginDate":"2011-04-12","endDate":null,"createdBy":"WHITES","dateCreated":"2011-04-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-7311-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Fibrocystic changes","valueDescription":"Breast Fibrocystic Change","ValueMeaning":{"publicId":"2974462","version":"1","preferredName":"Breast Fibrocystic Change","longName":"2974462","preferredDefinition":"A chronic disorder comprising three variants which range from lesions consisting primarily of an overgrowth of fibrous tissue to those characterized by dominance of the proliferation of the epithelial parenchyma to a form of dysplasia characterized by both stromal and epithelial hyperplasia with the formation of cysts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Fibrocystic Change","conceptCode":"C3039","definition":"Fibrosis associated with cyst formation in the breast parenchyma.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD8A964-F067-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-7326-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Paget disease of the nipple","valueDescription":"Paget Disease of the Nipple","ValueMeaning":{"publicId":"3669425","version":"1","preferredName":"Paget Disease of the Nipple","longName":"3669425","preferredDefinition":"A malignant epithelial cellular proliferation characterized by the presence of atypical cells with large nuclei and abundant pale cytoplasm within the squamous epithelium of the nipple.  In almost all cases there is an underlying intraductal breast carcinoma or intraductal and invasive carcinoma.  The skin changes range from redness to eczematous appearance.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nipple Paget Disease","conceptCode":"C3301","definition":"A malignant epithelial cellular proliferation characterized by the presence of atypical cells with large nuclei and abundant pale cytoplasm within the squamous epithelium of the nipple.  In almost all cases there is an underlying intraductal breast carcinoma or intraductal and invasive carcinoma.  The skin changes range from redness to eczematous appearance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-7334-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-734D-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Syringomatous adenoma","valueDescription":"Nipple Syringomatous Adenoma Adenoma","ValueMeaning":{"publicId":"3669427","version":"1","preferredName":"Nipple Syringomatous Adenoma Adenoma","longName":"3669427","preferredDefinition":"An invasive, non-metastasizing neoplasm with sweat duct differentiation that arises in the area of the nipple.  Local recurrences have been reported.: A neoplasm arising from the glandular epithelium.  It may be encapsulated or non-encapsulated.  The neoplastic epithelial cells may or may not display cellular atypia or dysplasia.  Representative examples are pituitary gland adenoma, follicular adenoma of the thyroid gland, and adenomas (or adenomatous polyps) of the gastrointestinal tract. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nipple Syringomatous Tumor","conceptCode":"C40363","definition":"An invasive, non-metastasizing neoplasm with sweat duct differentiation that arises in the area of the nipple.  Local recurrences have been reported.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenoma","conceptCode":"C2855","definition":"A neoplasm arising from the epithelium.  It may be encapsulated or non-encapsulated but non-invasive.  The neoplastic epithelial cells may or may not display cellular atypia or dysplasia.  In the gastrointestinal tract, when dysplasia becomes severe it is sometimes called carcinoma in situ.  Representative examples are pituitary gland adenoma, follicular adenoma of the thyroid gland, and adenomas (or adenomatous polyps) of the gastrointestinal tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-735B-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-7374-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Nipple adenoma","valueDescription":"Nipple Adenoma","ValueMeaning":{"publicId":"3669429","version":"1","preferredName":"Nipple Adenoma","longName":"3669429","preferredDefinition":"A benign epithelial neoplasm arising from the nipple. Signs and symptoms include serous or sanguineous nipple discharge and nipple erosion. It is characterized by the presence of aggregates of small tubules replacing the nipple stroma. The tubules are lined by epithelial and myoepithelial cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nipple Adenoma","conceptCode":"C4192","definition":"A benign epithelial neoplasm arising from the nipple. Signs and symptoms include serous or sanguineous nipple discharge and nipple erosion. It is characterized by the presence of aggregates of small tubules replacing the nipple stroma. The tubules are lined by epithelial and myoepithelial cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-7381-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-739A-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Mammary hamartoma","valueDescription":"Mammary Hamartoma","ValueMeaning":{"publicId":"3669430","version":"1","preferredName":"Mammary Hamartoma","longName":"3669430","preferredDefinition":"Having to do with the breast.: A benign and excessive tumor-like growth of mature cells and normal tissues which grow in a disorganized pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mammary","conceptCode":"C43595","definition":"Having to do with the breast.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hamartoma","conceptCode":"C3075","definition":"A benign and excessive tumor-like growth of mature cells and normal tissues which grow in a disorganized pattern.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-73A7-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-73C0-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Periductal stromal sarcoma, low grade","valueDescription":"Low Grade Periductal Breast Myoepitheliosis Stromal Sarcoma","ValueMeaning":{"publicId":"3669432","version":"1","preferredName":"Low Grade Periductal Breast Myoepitheliosis Stromal Sarcoma","longName":"3669432","preferredDefinition":"Used to describe tumor samples that exhibit well to moderately well differentiated cells. They are generally expected to be slow growing and less aggressive.: A neoplastic process characterized by the proliferation of spindle to cuboidal myoepithelial cells around small breast ducts.: A malignant neoplasm characterized by the presence of atypical mesenchymal-stromal cells. Representative examples include endometrial stromal sarcoma and prostate stromal sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Grade","conceptCode":"C14161","definition":"Used to describe tumor samples that exhibit well to moderately well differentiated cells. They are generally expected to be slow growing and less aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Breast Periductal Myoepitheliosis","conceptCode":"C40388","definition":"A neoplastic process characterized by the proliferation of spindle to cuboidal myoepithelial cells around small breast ducts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stromal Sarcoma","conceptCode":"C6926","definition":"A malignant neoplasm characterized by the presence of atypical mesenchymal-stromal cells. Representative examples include endometrial stromal sarcoma and prostate stromal sarcoma.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-73CF-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-73E8-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Phyllodes tumor Malignant","valueDescription":"Malignant Phyllodes Tumor","ValueMeaning":{"publicId":"3251786","version":"1","preferredName":"Malignant Phyllodes Tumor","longName":"3251786","preferredDefinition":"A phylodes tumor with sarcomatous stroma. The sarcomatous component is usually of the fibrosarcomatous type. Liposarcomatous, chondrosarcomatous, osteosarcomatous, or rhabdomyosarcomatous differentiation may also occur in the stroma. It may recur and metastasize following surgical resection. The lung and skeleton are the anatomic sites most frequently involved by metastases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Phyllodes Tumor","conceptCode":"C4275","definition":"A phyllodes tumor with sarcomatous stroma. The sarcomatous component is usually of the fibrosarcomatous type. Liposarcomatous, chondrosarcomatous, osteosarcomatous, or rhabdomyosarcomatous differentiation may also occur in the stroma. It may recur and metastasize following surgical resection. The lung and skeleton are the anatomic sites most frequently involved by metastases.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A76B8D07-93B2-4C3A-E040-BB89AD433F54","latestVersionIndicator":"Yes","beginDate":"2011-07-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-73FC-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Phyllodes tumor Borderline","valueDescription":"Borderline Phyllodes Tumor","ValueMeaning":{"publicId":"3669433","version":"1","preferredName":"Borderline Phyllodes Tumor","longName":"3669433","preferredDefinition":"Straddling the dividing line between two categories.: A benign, borderline, or malignant fibroepithelial neoplasm arising from the breast and rarely the prostate gland.  It may recur following resection.  The recurrence rates are higher for borderline and malignant phyllodes tumors.  In borderline and malignant phyllodes tumors metastases to distant anatomic sites can occur.  The incidence of metastases is higher in malignant phyllodes tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline","conceptCode":"C14157","definition":"Straddling the dividing line between two categories.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Phyllodes Tumor","conceptCode":"C2977","definition":"A benign, borderline, or malignant fibroepithelial neoplasm arising from the breast and rarely the prostate gland.  It may recur following resection.  The recurrence rates are higher for borderline and malignant phyllodes tumors.  In borderline and malignant phyllodes tumors metastases to distant anatomic sites can occur.  The incidence of metastases is higher in malignant phyllodes tumors.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-740A-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-7423-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Phyllodes tumor Benign","valueDescription":"Benign Phyllodes Tumor","ValueMeaning":{"publicId":"3669434","version":"1","preferredName":"Benign Phyllodes Tumor","longName":"3669434","preferredDefinition":"(beh-NINE) Not cancerous; does not invade nearby tissue or spread to other parts of the body.: A benign, borderline, or malignant fibroepithelial neoplasm arising from the breast and rarely the prostate gland.  It may recur following resection.  The recurrence rates are higher for borderline and malignant phyllodes tumors.  In borderline and malignant phyllodes tumors metastases to distant anatomic sites can occur.  The incidence of metastases is higher in malignant phyllodes tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Benign","conceptCode":"C14172","definition":"For neoplasms, a non-infiltrating and non-metastasizing neoplastic process that is characterized by the absence of morphologic features associated with malignancy (e.g., severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses). For other conditions, a process that is mild in nature and not dangerous to health.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Phyllodes Tumor","conceptCode":"C2977","definition":"A benign, borderline, or malignant fibroepithelial neoplasm arising from the breast and rarely the prostate gland.  It may recur following resection.  The recurrence rates are higher for borderline and malignant phyllodes tumors.  In borderline and malignant phyllodes tumors metastases to distant anatomic sites can occur.  The incidence of metastases is higher in malignant phyllodes tumors.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-7430-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-7449-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Fibroadenoma","valueDescription":"Fibroadenoma","ValueMeaning":{"publicId":"2566468","version":"1","preferredName":"Fibroadenoma","longName":"2566468","preferredDefinition":"This is the most common benign breast lesion.  It usually occurs in premenopausal women.  Diagnostic exams and procedures include: clinical exam, imaging (mammography and ultra sound), and tissue biopsy (fine-needle aspiration or core biopsy). -2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Fibroadenoma","conceptCode":"C3744","definition":"A benign tumor of the breast characterized by the presence of stromal and epithelial elements. It presents as a painless, solitary, slow growing, firm, and mobile mass. It is the most common benign breast lesion. It usually occurs in women of childbearing age. The majority of fibroadenomas do not recur after complete excision. A slightly increased risk of developing cancer within fibroadenomas or in the breast tissue of patients previously treated for fibroadenomas has been reported.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D0B1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-08-11","modifiedBy":"REEVESD","dateModified":"2010-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-7453-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Soft tissue sarcoma","valueDescription":"Soft Tissue Sarcoma","ValueMeaning":{"publicId":"3384698","version":"1","preferredName":"Soft Tissue Sarcoma","longName":"3384698","preferredDefinition":"A malignant mesenchymal neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Soft Tissue Sarcoma","conceptCode":"C9306","definition":"A malignant neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9A3DDB0-75C8-1600-E040-BB89AD432CFF","latestVersionIndicator":"Yes","beginDate":"2012-02-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-7468-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Soft tissue tumor - Benign","valueDescription":"Benign Soft Tissue Neoplasm","ValueMeaning":{"publicId":"3669436","version":"1","preferredName":"Benign Soft Tissue Neoplasm","longName":"3669436","preferredDefinition":"(beh-NINE) Not cancerous; does not invade nearby tissue or spread to other parts of the body.: A benign or malignant neoplasm that arises from mesenchymal cells in extra skeletal sites.  The most common types are lipomatous (fatty), vascular, smooth muscle, fibrous, and fibrohistiocytic neoplasms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Benign","conceptCode":"C14172","definition":"For neoplasms, a non-infiltrating and non-metastasizing neoplastic process that is characterized by the absence of morphologic features associated with malignancy (e.g., severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses). For other conditions, a process that is mild in nature and not dangerous to health.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Soft Tissue Neoplasm","conceptCode":"C3377","definition":"A benign, intermediate, or malignant neoplasm that arises from the soft tissue.  The most common types are lipomatous (fatty), vascular, smooth muscle, fibrous, and fibrohistiocytic neoplasms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-7477-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-7490-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Hemangioma","valueDescription":"Hemangioma","ValueMeaning":{"publicId":"3252167","version":"1","preferredName":"Hemangioma","longName":"3252167","preferredDefinition":"A benign localized vascular neoplasm usually occurring in infancy and childhood. It is characterized by the formation of capillary-sized or cavernous vascular channels. The majority of cases are congenital.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemangioma","conceptCode":"C3085","definition":"A benign vascular lesion characterized by the formation of capillary-sized or cavernous vascular channels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A78372C6-E34F-4779-E040-BB89AD432A7F","latestVersionIndicator":"Yes","beginDate":"2011-07-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-74C7-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Malignant myoepithelioma","valueDescription":"Malignant Myoepithelioma","ValueMeaning":{"publicId":"3248547","version":"1","preferredName":"Malignant Myoepithelioma","longName":"3248547","preferredDefinition":"An infiltrating malignant epithelial neoplasm characterized by the presence of atypical cells with myoepithelial differentiation. Representative examples include malignant breast myoepithelioma and salivary gland myoepithelial carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Myoepithelioma","conceptCode":"C7596","definition":"An infiltrating malignant tumor characterized by the presence of atypical cells with myoepithelial differentiation. Representative examples include malignant breast myoepithelioma and salivary gland myoepithelial carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-BB70-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-74DC-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Adenomyoepithelioma","valueDescription":"Breast Adenomyoepithelioma","ValueMeaning":{"publicId":"3247920","version":"1","preferredName":"Breast Adenomyoepithelioma","longName":"3247920","preferredDefinition":"A usually benign neoplasm arising from the breast. It is characterized by the proliferation of cells with myoepithelial differentiation around spaces which are lined by epithelial cells. Rarely, the epithelial and/or myoepithelial cells may undergo malignant transformation. Cases with malignant transformation may follow an aggressive clinical course, including recurrences and local and distant metastases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Adenomyoepithelioma","conceptCode":"C6899","definition":"A usually benign tumor arising from the breast. It is characterized by the proliferation of cells with myoepithelial differentiation around spaces which are lined by epithelial cells. Rarely, the epithelial and/or myoepithelial cells may undergo malignant transformation. Cases with malignant transformation may follow an aggressive clinical course, including recurrences and local and distant metastases.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A67B3AED-05BA-CE90-E040-BB89AD433EDB","latestVersionIndicator":"Yes","beginDate":"2011-06-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-74E7-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Ductal adenoma","valueDescription":"Breast Ductal Adenoma","ValueMeaning":{"publicId":"3669439","version":"1","preferredName":"Breast Ductal Adenoma","longName":"3669439","preferredDefinition":"A benign, well circumscribed neoplasm that is located within the lumen of a duct in the breast parenchyma.  It is characterized by the presence of glandular structures at the periphery and fibrous tissue at the center of the tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Adenoma","conceptCode":"C40384","definition":"A benign, well circumscribed neoplasm that is located within the lumen of a duct in the breast parenchyma.  It is characterized by the presence of glandular structures at the periphery and fibrous tissue at the center of the tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-74F5-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-750E-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Pleomorphic adenoma","valueDescription":"Pleomorphic Adenoma","ValueMeaning":{"publicId":"3247861","version":"1","preferredName":"Pleomorphic Adenoma","longName":"3247861","preferredDefinition":"A neoplasm characterized by the presence of benign epithelial and myoepithelial cells and a mesenchymal component that may contain mucoid, myxoid, cartilaginous, or osseous areas. It may be completely or partially encapsulated. It occurs in the parotid gland, submandibular gland, minor salivary glands in the oral cavity, upper respiratory tract, and nasal cavity and paranasal sinuses. It usually presents as a slow growing painless mass. Infrequently, patients may present with pain and facial palsy. It may recur after excision or transform to a malignant neoplasm (carcinoma ex pleomorphic adenoma).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pleomorphic Adenoma","conceptCode":"C8602","definition":"A neoplasm characterized by the presence of benign epithelial and myoepithelial cells and a mesenchymal component that may contain mucoid, myxoid, cartilaginous, or osseous areas. It may be completely or partially encapsulated. It occurs in the parotid gland, submandibular gland, minor salivary glands in the oral cavity, upper respiratory tract, and nasal cavity and paranasal sinuses. It usually presents as a slow growing painless mass. Infrequently, patients may present with pain and facial palsy. It may recur after excision or transform to a malignant neoplasm (carcinoma ex pleomorphic adenoma).","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A67A743F-5ED2-D6C3-E040-BB89AD436761","latestVersionIndicator":"Yes","beginDate":"2011-06-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-7522-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Apocrine adenoma","valueDescription":"Apocrine Adenoma","ValueMeaning":{"publicId":"3669441","version":"1","preferredName":"Apocrine Adenoma","longName":"3669441","preferredDefinition":"A benign epithelial neoplasm arising from the apocrine sweat glands. Representative examples include tubular apocrine adenoma and external auditory canal ceruminous adenoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Apocrine Adenoma","conceptCode":"C4168","definition":"A benign epithelial neoplasm arising from the apocrine sweat glands. Representative examples include tubular apocrine adenoma and external auditory canal ceruminous adenoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-7530-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-7549-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Lactating adenoma","valueDescription":"Lactating Adenoma","ValueMeaning":{"publicId":"3669443","version":"1","preferredName":"Lactating Adenoma","longName":"3669443","preferredDefinition":"A tubular type adenoma of the breast in which, during pregnancy and lactation, the epithelial cells show extensive secretory changes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lactating Adenoma","conceptCode":"C9473","definition":"A tubular type adenoma of the breast in which, during pregnancy and lactation, the epithelial cells show extensive secretory changes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-7556-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-756F-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Tubular adenoma","valueDescription":"Tubular Adenoma","ValueMeaning":{"publicId":"3247845","version":"1","preferredName":"Tubular Adenoma","longName":"3247845","preferredDefinition":"A usually polypoid neoplasm arising from the glandular epithelium. It is characterized by a tubular architectural pattern. The neoplastic glandular cells have dysplastic features. Representative examples include the tubular adenomas of the colon and rectum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tubular Adenoma","conceptCode":"C4133","definition":"An adenoma arising from the glandular epithelium of the gastrointestinal tract. It is characterized by the presence of a tubular architectural pattern. Most often it occurs in the large intestine, small intestine, and the stomach. The neoplastic epithelial cells show dysplastic features.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A67A743F-5D8B-D6C3-E040-BB89AD436761","latestVersionIndicator":"Yes","beginDate":"2011-06-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-7583-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Radial scar / complex sclerosing lesion","valueDescription":"Radial Scar/Complex Sclerosing Lesion","ValueMeaning":{"publicId":"3248680","version":"1","preferredName":"Radial Scar/Complex Sclerosing Lesion","longName":"3248680","preferredDefinition":"A benign breast lesion characterized by the presence of fibrosis with stellate appearance in the parenchyma. The lesions are often multiple and bilateral. Grossly, the lesions are irregular and firm and resemble carcinoma. Microscopically, the stellate lesions are composed of dense, hyalinized collagen. Entrapped in the collagen are tubules. There is no evidence of cytologic atypia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radial Scar/Complex Sclerosing Lesion","conceptCode":"C9495","definition":"A benign breast lesion characterized by the presence of fibrosis with stellate appearance in the parenchyma.  The lesions are often multiple and bilateral.  Grossly, the lesions are irregular and firm and resemble carcinoma.  Microscopically, the stellate lesions are composed of dense, hyalinized collagen.  Entrapped in the collagen are tubules.  There is no evidence of cytologic atypia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6C6E274-6BC3-2DEF-E040-BB89AD4337BB","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-7597-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Adenosis including variants: sclerosing adenosis, apocrine adenosis, blunt duct adenosis, microglandular adenosis, adenomyoepithelial adenosis","valueDescription":"Breast Adenosis","ValueMeaning":{"publicId":"3249224","version":"1","preferredName":"Breast Adenosis","longName":"3249224","preferredDefinition":"A non-neoplastic disorder characterized by epithelial and/or myoepithelial tissue growth in the breast lobules.  It may be associated with apocrine changes or sclerosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Adenosis","conceptCode":"C3484","definition":"A non-neoplastic disorder characterized by epithelial and/or myoepithelial tissue growth in the breast lobules.  It may be associated with apocrine changes or sclerosis.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6CA5E9E-1D13-D7DA-E040-BB89AD432E47","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-75AC-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Intracystic papillary carcinoma","valueDescription":"Intracystic Papillary Breast Carcinoma","ValueMeaning":{"publicId":"3243455","version":"1","preferredName":"Intracystic Papillary Breast Carcinoma","longName":"3243455","preferredDefinition":"An intraductal breast carcinoma characterized by a papillary growth within a large cystic duct. There is no evidence of invasion of the breast parenchyma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Intracystic Papillary Carcinoma","conceptCode":"C7645","definition":"An intraductal breast carcinoma characterized by a papillary growth within a large cystic duct. There is no evidence of invasion of the breast parenchyma.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A55A32E7-339B-D7C0-E040-BB89AD437508","latestVersionIndicator":"Yes","beginDate":"2011-06-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-06-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-75C1-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Intraductal papillary carcinoma","valueDescription":"Intraductal Papillary Breast Carcinoma","ValueMeaning":{"publicId":"3669445","version":"1","preferredName":"Intraductal Papillary Breast Carcinoma","longName":"3669445","preferredDefinition":"A non-invasive breast adenocarcinoma located in a distended duct. It is characterized by the presence of papillary structures with fibrovascular stalks. In the absence of ductal carcinoma in situ or invasive carcinoma in adjacent tissues, the prognosis is usually favorable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Papillary Ductal Carcinoma In Situ","conceptCode":"C4190","definition":"Breast ductal carcinoma in situ characterized by the presence of filiform arborizing fibrovascular cores lined by neoplastic ductal epithelium. (WHO 2019)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-75CF-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-75E8-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Atypical papilloma","valueDescription":"Atypical Papilloma","ValueMeaning":{"publicId":"3669446","version":"1","preferredName":"Atypical Papilloma","longName":"3669446","preferredDefinition":"Varying from the norm.: A benign epithelial neoplasm that projects above the surrounding epithelial surface and consists of villous or arborescent outgrowths of fibrovascular stroma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atypical","conceptCode":"C25428","definition":"Varying from the norm; not conformable to the type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Papilloma","conceptCode":"C7440","definition":"A benign epithelial neoplasm that projects above the surrounding epithelial surface and consists of villous or arborescent outgrowths of fibrovascular stroma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-75F5-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-760E-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Peripheral papilloma","valueDescription":"Peripheral Papilloma","ValueMeaning":{"publicId":"3669447","version":"1","preferredName":"Peripheral Papilloma","longName":"3669447","preferredDefinition":"On or near an edge or constituting an outer boundary; the outer area.: A benign epithelial neoplasm that projects above the surrounding epithelial surface and consists of villous or arborescent outgrowths of fibrovascular stroma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Peripheral","conceptCode":"C25233","definition":"On or near an edge or constituting an outer boundary; the outer area.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Papilloma","conceptCode":"C7440","definition":"A benign epithelial neoplasm that projects above the surrounding epithelial surface and consists of villous or arborescent outgrowths of fibrovascular stroma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-761B-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-7634-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Central papilloma","valueDescription":"Center Papilloma","ValueMeaning":{"publicId":"3669448","version":"1","preferredName":"Center Papilloma","longName":"3669448","preferredDefinition":"A point or area that is approximately central within some larger region or structure.: A benign epithelial neoplasm that projects above the surrounding epithelial surface and consists of villous or arborescent outgrowths of fibrovascular stroma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Center","conceptCode":"C25445","definition":"A point or area that is approximately central within some larger region or structure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Papilloma","conceptCode":"C7440","definition":"A benign epithelial neoplasm that projects above the surrounding epithelial surface and consists of villous or arborescent outgrowths of fibrovascular stroma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-7641-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-765A-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Microinvasive carcinoma","valueDescription":"Microinvasive Carcinoma","ValueMeaning":{"publicId":"3669449","version":"1","preferredName":"Microinvasive Carcinoma","longName":"3669449","preferredDefinition":"Exhibiting or pertaining to microinvasion, the microscopic extension of malignant cells into adjacent tissue in carcinoma in situ.: A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Microinvasive","conceptCode":"C25568","definition":"Exhibiting or pertaining to microinvasion, the microscopic extension of malignant cells into adjacent tissue in carcinoma in situ.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-7667-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-7680-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Ductal carcinoma in situ","valueDescription":"Ductal Carcinoma In Situ","ValueMeaning":{"publicId":"3262799","version":"1","preferredName":"Ductal Carcinoma In Situ","longName":"3262799","preferredDefinition":"A carcinoma entirely confined to the mammary ducts.  It is also known as DCIS.  There is no evidence of invasion of the basement membrane.  Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis.  The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAB50210-A094-7298-E040-BB89AD4308A3","latestVersionIndicator":"Yes","beginDate":"2011-08-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-08-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-7694-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Atypical ductal hyperplasia","valueDescription":"Atypical Ductal Breast Hyperplasia","ValueMeaning":{"publicId":"3250150","version":"1","preferredName":"Atypical Ductal Breast Hyperplasia","longName":"3250150","preferredDefinition":"A benign (not cancer) condition in which there are more cells than normal in the breast lobules and the cells look abnormal under a microscope. Having atypical lobular hyperplasia increases the risk of breast cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Atypical Ductal Hyperplasia","conceptCode":"C8436","definition":"A neoplastic process that arises from the terminal ductal lobular unit of the breast parenchyma.  It is usually solitary and confined to a single lobular unit.  It is characterized by the presence of a monomorphic epithelial proliferation in a cribriform, micropapillary, or solid growth pattern.  Focal architectural features of low grade ductal carcinoma in situ are present.  There is an increased risk for development of invasive breast carcinoma.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6DE8128-E8BF-E018-E040-BB89AD437315","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-76A9-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Flat epithelial atypia","valueDescription":"Flat Ductal Epithelial Atypia of the Breast","ValueMeaning":{"publicId":"3669451","version":"1","preferredName":"Flat Ductal Epithelial Atypia of the Breast","longName":"3669451","preferredDefinition":"A breast lesion characterized by the presence of dilated terminal ductal lobular units in which the epithelial lining has been replaced by a single layer of mildly atypical cells, or there is atypical, monotonous epithelial hyperplasia of three to five layers.  This lesion relates to columnar cell change with atypia and columnar cell hyperplasia with atypia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Flat Ductal Epithelial Atypia","conceptCode":"C36086","definition":"A breast lesion characterized by the presence of dilated terminal ductal lobular units in which the epithelial lining has been replaced by a single layer of mildly atypical cells, or there is atypical, monotonous epithelial hyperplasia of three to five layers.  This lesion relates to columnar cell change with atypia and columnar cell hyperplasia with atypia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-76B7-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-76D0-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Usual ductal hyperplasia","valueDescription":"Usual Ductal Hyperplasia","ValueMeaning":{"publicId":"3669452","version":"1","preferredName":"Usual Ductal Hyperplasia","longName":"3669452","preferredDefinition":"That which is considered customary.: Ductal; related to, or having the quality of, a duct.: An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Usual","conceptCode":"C102843","definition":"That which is considered customary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Ductal","conceptCode":"C25732","definition":"Related to, or having the quality of, a duct.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hyperplasia","conceptCode":"C3113","definition":"An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-76DE-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-76F7-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Lobular carcinoma in situ","valueDescription":"Lobular Carcinoma In Situ","ValueMeaning":{"publicId":"3251341","version":"1","preferredName":"Lobular Carcinoma In Situ","longName":"3251341","preferredDefinition":"A non-invasive adenocarcinoma of the breast characterized by a proliferation of monomorphic cells completely filling the lumina.  The overall lobular architecture is preserved.  It is frequently multifocal (90% in some series) and bilateral.  It seldom becomes invasive; however there is an increased risk of infiltrating ductal adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Lobular Carcinoma In Situ","conceptCode":"C4018","definition":"A non-invasive adenocarcinoma of the breast characterized by a proliferation of monomorphic cells completely filling the lumina.  The overall lobular architecture is preserved.  It is frequently multifocal (90% in some series) and bilateral.  It seldom becomes invasive; however there is an increased risk of infiltrating ductal adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A758F49E-9DB9-73F4-E040-BB89AD430DFE","latestVersionIndicator":"Yes","beginDate":"2011-07-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-770B-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Lobular neoplasia","valueDescription":"Lobular Neoplasia","ValueMeaning":{"publicId":"3669454","version":"1","preferredName":"Lobular Neoplasia","longName":"3669454","preferredDefinition":"A spectrum of non-invasive neoplastic lesions that arise from the terminal ductal lobular units of the breast.  There is atypical small epithelial cell proliferation.  Pagetoid involvement of the terminal ducts may or may not be present.  In the minority of cases, there is a risk for subsequent development of invasive ductal or invasive lobular carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Lobular Neoplasia","conceptCode":"C27939","definition":"A spectrum of non-invasive neoplastic lesions that arise from the terminal ductal lobular units of the breast.  There is atypical small epithelial cell proliferation.  Pagetoid involvement of the terminal ducts may or may not be present.  In the minority of cases, there is a risk for subsequent development of invasive ductal or invasive lobular carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-7719-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-7732-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Inflammatory carcinoma","valueDescription":"Inflammatory Breast Carcinoma","ValueMeaning":{"publicId":"2593123","version":"1","preferredName":"Inflammatory Breast Carcinoma","longName":"2593123","preferredDefinition":"A type of breast cancer in which the breast looks red and swollen and feels warm. The skin of the breast may also show the pitted appearance called peau d'orange (like the skin of an orange). The redness and warmth occur because the cancer cells block the lymph vessels in the skin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Inflammatory Carcinoma","conceptCode":"C4001","definition":"An advanced, invasive breast adenocarcinoma characterized by the presence of distinct changes in the overlying skin. These changes include diffuse erythema, edema, peau d'orange (skin of an orange) appearance, tenderness, induration, warmth, enlargement, and in some cases a palpable mass. The skin changes are the consequence of lymphatic obstruction from the underlying invasive breast adenocarcinoma. Microscopically, the dermal lymphatics show prominent infiltration by malignant cells. The invasive breast adenocarcinoma is usually of ductal, NOS type. There is not significant inflammatory cell infiltrate present, despite the name of this carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"286D4DB6-4D39-242A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-7746-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Acinic cell carcinoma","valueDescription":"Acinar Cell Carcinoma","ValueMeaning":{"publicId":"2558157","version":"1","preferredName":"Acinar Cell Carcinoma","longName":"2558157","preferredDefinition":"A malignant glandular epithelial neoplasm consisting of secretory cells forming acinar patterns. Representative examples include the acinar cell carcinoma of the pancreas and the acinar adenocarcinoma of the prostate gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acinar Cell Carcinoma","conceptCode":"C3768","definition":"A malignant glandular epithelial neoplasm consisting of secretory cells forming acinar patterns. Representative examples include the acinar cell carcinoma of the pancreas and the acinar adenocarcinoma of the prostate gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B03A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-775B-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Adenoid cystic carcinoma","valueDescription":"Adenoid Cystic Carcinoma","ValueMeaning":{"publicId":"3293695","version":"1","preferredName":"Adenoid Cystic Carcinoma","longName":"3293695","preferredDefinition":"A malignant tumor arising from the epithelial cells. Microscopically, the neoplastic epithelial cells form cylindrical spatial configurations (cribriform or classic type of adenoid cystic carcinoma), cordlike structures (tubular type of adenoid cystic carcinoma), or solid structures (basaloid variant of adenoid cystic carcinoma). Adenoid cystic carcinomas mostly occur in the salivary glands. Other primary sites of involvement include the lacrimal gland, the larynx, and the lungs. Adenoid cystic carcinomas spread along nerve sheaths, resulting in severe pain, and they tend to recur. Lymph node metastases are unusual; hematogenous tumor spread is characteristic.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenoid Cystic Carcinoma","conceptCode":"C2970","definition":"A malignant tumor arising from the epithelial cells.  Microscopically, the neoplastic epithelial cells form cylindrical spatial configurations (cribriform or classic type of adenoid cystic carcinoma), cordlike structures (tubular type of adenoid cystic carcinoma), or solid structures (basaloid variant of adenoid cystic carcinoma).  Adenoid cystic carcinomas mostly occur in the salivary glands.  Other primary sites of involvement include the lacrimal gland, the larynx, and the lungs.  Adenoid cystic carcinomas spread along nerve sheaths, resulting in severe pain, and they tend to recur.  Lymph node metastases are unusual; hematogenous tumor spread is characteristic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF074E37-E6DE-1C17-E040-BB89AD431694","latestVersionIndicator":"Yes","beginDate":"2011-10-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2011-10-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-7765-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Secretory carcinoma","valueDescription":"Secretory Breast Carcinoma","ValueMeaning":{"publicId":"2581224","version":"1","preferredName":"Secretory Breast Carcinoma","longName":"2581224","preferredDefinition":"A rare, low grade invasive adenocarcinoma of the breast characterized by the presence of cells that secrete milk-like material. Morphologically, it usually appears as a circumscribed lesion, composed of cystic spaces, tubular structures, and solid areas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Secretory Carcinoma","conceptCode":"C4189","definition":"A rare, low grade invasive adenocarcinoma of the breast characterized by the presence of cells that secrete milk-like material. Morphologically, it usually appears as a circumscribed lesion, composed of cystic spaces, tubular structures, and solid areas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A55-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"CURTIST","dateModified":"2006-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-777A-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Lipid-rich carcinoma","valueDescription":"Lipid-Rich Carcinoma","ValueMeaning":{"publicId":"3669456","version":"1","preferredName":"Lipid-Rich Carcinoma","longName":"3669456","preferredDefinition":"A carcinoma characterized by the presence of malignant epithelial cells with clear cytoplasm which contains neutral lipids. A representative example is the lipid-rich breast carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lipid-Rich Carcinoma","conceptCode":"C4152","definition":"A carcinoma characterized by the presence of malignant epithelial cells with clear cytoplasm which contains neutral lipids. A representative example is the lipid-rich breast carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-7788-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-77A1-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Squamous cell carcinoma","valueDescription":"Squamous Cell Carcinoma","ValueMeaning":{"publicId":"3300679","version":"1","preferredName":"Squamous Cell Carcinoma","longName":"3300679","preferredDefinition":"A carcinoma arising from squamous epithelial cells. Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells. Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells. Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Squamous Cell Carcinoma","conceptCode":"C2929","definition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B126E752-C52C-5EF2-E040-BB89AD43398A","latestVersionIndicator":"Yes","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-77B5-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Metaplastic carcinomas","valueDescription":"Metaplastic Carcinoma","ValueMeaning":{"publicId":"3248487","version":"1","preferredName":"Metaplastic Carcinoma","longName":"3248487","preferredDefinition":"A general term used to describe carcinomas arising from epithelial cells that have been transformed into another cells type (metaplastic epithelial cells). A representative example is the adenocarcinoma arising in Barrett esophagus. This term is also used to describe carcinomas in which the malignant epithelial cells show differentiation towards another cell type. A representative example of the latter is the metaplastic breast carcinoma in which the malignant glandular cells show squamous, spindle cell, or chondroid/osseous differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metaplastic Carcinoma","conceptCode":"C27949","definition":"A general term used to describe carcinomas arising from epithelial cells that have been transformed into another cells type (metaplastic epithelial cells). A representative example is the adenocarcinoma arising in Barrett esophagus. This term is also used to describe carcinomas in which the malignant epithelial cells show differentiation towards another cell type. A representative example of the latter is the metaplastic breast carcinoma in which the malignant glandular cells show squamous, spindle cell, or chondroid/osseous differentiation.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6B8531E-1718-F891-E040-BB89AD4324F8","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-77CA-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Apocrine carcinoma","valueDescription":"Apocrine Gland Carcinoma","ValueMeaning":{"publicId":"3248218","version":"1","preferredName":"Apocrine Gland Carcinoma","longName":"3248218","preferredDefinition":"A carcinoma with apocrine differentiation arising from the sweat glands. It presents as single or multiple nodular lesions which may be ulcerated or hemorrhagic and is usually in the axilla and less often in the anogenital region. It grows in the dermis and infiltrates subcutaneous tissues. It is characterized by the presence of large cells with abundant eosinophilic cytoplasm and large often vesicular nuclei. Most cases are slow growing tumors and have a prolonged course.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Apocrine Carcinoma","conceptCode":"C4169","definition":"A carcinoma with apocrine differentiation arising from the sweat glands. It presents as single or multiple nodular lesions which may be ulcerated or hemorrhagic and is usually in the axilla and less often in the anogenital region. It grows in the dermis and infiltrates subcutaneous tissues. It is characterized by the presence of large cells with abundant eosinophilic cytoplasm and large often vesicular nuclei. Most cases are slow growing tumors and have a prolonged course.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6B537E2-80D0-5E57-E040-BB89AD4339B4","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-77DF-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Invasive papillary carcinoma","valueDescription":"Invasive Papillary Carcinoma","ValueMeaning":{"publicId":"3669457","version":"1","preferredName":"Invasive Papillary Carcinoma","longName":"3669457","preferredDefinition":"Marked by a tendency to spread especially into healthy tissue.: of or relating to or resembling papilla.: A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive","conceptCode":"C14159","definition":"Marked by a tendency to spread, especially into healthy surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Papillary","conceptCode":"C14166","definition":"Of or relating to or resembling papilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-77EE-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-7807-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Invasive micropapillary carcinoma","valueDescription":"Invasive Micropapillary Breast Carcinoma","ValueMeaning":{"publicId":"3248497","version":"1","preferredName":"Invasive Micropapillary Breast Carcinoma","longName":"3248497","preferredDefinition":"An invasive breast carcinoma characterized by the presence of clusters of malignant cells located within artifactual clear stromal spaces that resemble vascular spaces.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Micropapillary Carcinoma","conceptCode":"C36084","definition":"An invasive breast carcinoma characterized by the presence of clusters of malignant cells located within artifactual clear stromal spaces that resemble vascular spaces.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6B8531E-17EB-F891-E040-BB89AD4324F8","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-781B-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Solid neuroendocrine carcinoma","valueDescription":"Solid Neuroendocrine System Carcinoma","ValueMeaning":{"publicId":"3669458","version":"1","preferredName":"Solid Neuroendocrine System Carcinoma","longName":"3669458","preferredDefinition":"The state in which a substance has no tendency to flow under moderate stress; resists forces (such as compression) that tend to deform it; and retains a definite size and shape.: (NOO-ro-EN-do-krin) Having to do with the interactions between the nervous system and the endocrine system.  Neuroendocrine describes certain cells that release hormones into the blood in response to stimulation of the nervous system.: A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Solid","conceptCode":"C45300","definition":"The state in which a substance has no tendency to flow under moderate stress; resists forces (such as compression) that tend to deform it; and retains a definite size and shape.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Neuroendocrine System","conceptCode":"C12945","definition":"A system of neurosecretory neurons that release hormones to the circulatory system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-782A-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-7843-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Mucinous carcinoma","valueDescription":"Mucinous Breast Carcinoma","ValueMeaning":{"publicId":"3243624","version":"1","preferredName":"Mucinous Breast Carcinoma","longName":"3243624","preferredDefinition":"An invasive adenocarcinoma of the breast characterized by the presence of islands of small and uniform cells, surrounded by large amounts of mucin. Pure mucinous breast carcinomas have generally a favorable prognosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Mucinous Carcinoma","conceptCode":"C9131","definition":"An invasive adenocarcinoma of the breast characterized by the presence of islands of small and uniform cells, surrounded by large amounts of mucin.  Pure mucinous breast carcinomas generally have a favorable prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A55DCBB1-7268-F00A-E040-BB89AD431D27","latestVersionIndicator":"Yes","beginDate":"2011-06-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-06-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-7857-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Medullary carcinoma","valueDescription":"Medullary Breast Carcinoma","ValueMeaning":{"publicId":"3669459","version":"1","preferredName":"Medullary Breast Carcinoma","longName":"3669459","preferredDefinition":"An infiltrating breast carcinoma distinguished by its allegedly good prognosis. Medullary breast carcinoma is uncommon, accounting for fewer than 1% of all infiltrating breast carcinomas. Grossly, this is a well circumscribed tumor, with soft cut surface ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Medullary Carcinoma","conceptCode":"C9119","definition":"An infiltrating breast carcinoma with a relatively favorable prognosis.  It is an uncommon carcinoma, accounting for less than 1% of all infiltrating breast carcinomas.  It is well circumscribed, with soft cut surface and often of considerable size.  Microscopically, the predominant growth pattern is syncytial with broad anastomosing bands or sheets of malignant cells.  The malignant cells are round with abundant cytoplasm and vesicular nuclei.  The sheets of malignant cells are associated with a marked lymphoplasmacytic infiltrate.  Glandular or tubular structures are absent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-7862-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-787B-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Invasive cribriform carcinoma","valueDescription":"Invasive Cribriform Breast Carcinoma","ValueMeaning":{"publicId":"2581150","version":"1","preferredName":"Invasive Cribriform Breast Carcinoma","longName":"2581150","preferredDefinition":"An invasive adenocarcinoma of the breast with a favorable clinical outcome, characterized by the presence of a sieve-like or cribriform infiltrating pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Cribriform Carcinoma","conceptCode":"C5142","definition":"An invasive adenocarcinoma of the breast with a favorable clinical outcome, characterized by the presence of a sieve-like or cribriform infiltrating pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A0B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-788F-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Tubular carcinoma","valueDescription":"Tubular Breast Carcinoma","ValueMeaning":{"publicId":"3669460","version":"1","preferredName":"Tubular Breast Carcinoma","longName":"3669460","preferredDefinition":"An invasive adenocarcinoma of the breast with a favorable prognosis. It is composed of tubular structures lined by a single layer of epithelium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Tubular Carcinoma","conceptCode":"C9135","definition":"An invasive adenocarcinoma of the breast with a favorable prognosis.  It is composed of tubular structures lined by a single layer of epithelium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-789A-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-78B3-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Invasive lobular carcinoma","valueDescription":"Invasive Lobular Breast Carcinoma","ValueMeaning":{"publicId":"2581147","version":"1","preferredName":"Invasive Lobular Breast Carcinoma","longName":"2581147","preferredDefinition":"An infiltrating lobular adenocarcinoma.  The malignant cells lack cohesion and are arranged individually or in a linear manner (Indian files), or as narrow trabeculae within the stroma.  The malignant cells are usually smaller than those of ductal carcinoma, are less pleomorphic, and have fewer mitotic figures. --2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Lobular Carcinoma","conceptCode":"C7950","definition":"An infiltrating lobular adenocarcinoma of the breast.  The malignant cells lack cohesion and are arranged individually or in a linear manner (Indian files), or as narrow trabeculae within the stroma.  The malignant cells are usually smaller than those of ductal carcinoma, are less pleomorphic, and have fewer mitotic figures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A08-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-78BD-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Carcinoma with osteoclastic giant cells","valueDescription":"Breast Carcinoma with Osteoclastic Giant Cells","ValueMeaning":{"publicId":"3669462","version":"1","preferredName":"Breast Carcinoma with Osteoclastic Giant Cells","longName":"3669462","preferredDefinition":"An invasive breast adenocarcinoma characterised by the presence of non-neoplastic stromal osteoclastic giant cells.  The carcinomatous component is usually an invasive ductal carcinoma, although all other breast adenocarcinoma subtypes have also been described.  The prognosis depends on the characteristics of the adenocarcinomatous component, and is not related to the presence of the giant cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma with Osteoclast-Like Stromal Giant Cells","conceptCode":"C40349","definition":"An invasive breast adenocarcinoma characterised by the presence of non-neoplastic stromal osteoclastic giant cells.  The carcinomatous component is usually an invasive ductal carcinoma, although all other breast adenocarcinoma subtypes have also been described.  The prognosis depends on the characteristics of the adenocarcinomatous component, and is not related to the presence of the giant cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-78CB-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-78E4-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Pleomorphic carcinoma","valueDescription":"Pleomorphic Carcinoma","ValueMeaning":{"publicId":"3669464","version":"1","preferredName":"Pleomorphic Carcinoma","longName":"3669464","preferredDefinition":"A usually aggressive malignant epithelial neoplasm composed of cells with significant cytologic atypia and nuclear pleomorphism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pleomorphic Carcinoma","conceptCode":"C4094","definition":"A usually aggressive malignant epithelial neoplasm composed of cells with significant cytologic atypia and nuclear pleomorphism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-78F1-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-790A-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Mixed type carcinoma","valueDescription":"Mixed Type Carcinoma","ValueMeaning":{"publicId":"3669465","version":"1","preferredName":"Mixed Type Carcinoma","longName":"3669465","preferredDefinition":"Involving or composed of different kinds.: Something distinguishable as an identifiable class based on common qualities.: A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed","conceptCode":"C25259","definition":"Involving or composed of different kinds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-7918-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-7931-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Invasive ductal carcinoma, not otherwise specified (NOS)","valueDescription":"Invasive Ductal Carcinoma, Not Otherwise Specified","ValueMeaning":{"publicId":"2581223","version":"1","preferredName":"Invasive Ductal Carcinoma, Not Otherwise Specified","longName":"2581223","preferredDefinition":"Invasive ductal carcinoma is the most common type of invasive breast carcinoma (accounting for approximately 70% of breast carcinomas). The gross appearance is usually typical with an irregular stellate outline. Microscopically, randomly arranged epithelial elements are seen. When large sheets of malignant cells are present, necrosis may be seen. With adequate tissue sampling, in situ carcinoma can be demonstrated in association with the infiltrating carcinoma. The in situ component is nearly always ductal but occasionally may be lobular or both. --2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Carcinoma of No Special Type","conceptCode":"C4194","definition":"A term that refers to a large and heterogeneous group of invasive breast carcinomas that cannot be classified morphologically as any of the special histological types. (WHO 2019)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A54-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"CURTIST","dateModified":"2006-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4858C70-7945-328A-E040-BB89AD433B84","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Pseudoangiomatous stromal hyperplasia","valueDescription":"Pseudoangiomatous Stromal Hyperplasia","ValueMeaning":{"publicId":"3673377","version":"1","preferredName":"Pseudoangiomatous Stromal Hyperplasia","longName":"3673377","preferredDefinition":"A benign proliferation of the stromal cells in the breast. It is classified as simple, when associated with the presence of slit-like spaces without erythrocytes and as fascicular/proliferative, when spindle cell proliferation without atypia is present. It is often seen in breast tissue specimens as small foci associated with benign epithelial lesions. Pseudoangiomatous stromal hyperplasia presenting as a well-circumscribed palpable mass is rare.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pseudoangiomatous Stromal Hyperplasia","conceptCode":"C104373","definition":"A benign proliferation of the stromal cells in the breast.  It is classified as simple, when associated with the presence of slit-like spaces without erythrocytes and as fascicular/proliferative, when spindle cell proliferation without atypia is present.  It is often seen in breast tissue specimens as small foci associated with benign epithelial lesions.  Pseudoangiomatous stromal hyperplasia presenting as a well-circumscribed palpable mass is rare.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4983CA8-517F-9270-E040-BB89AD435CCD","latestVersionIndicator":"Yes","beginDate":"2013-01-31","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4983CA8-5198-9270-E040-BB89AD435CCD","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-31","modifiedBy":"ONEDATA","dateModified":"2013-01-31","deletedIndicator":"No"},{"value":"Sebaceous carcinoma","valueDescription":"Sebaceous Carcinoma","ValueMeaning":{"publicId":"3248527","version":"1","preferredName":"Sebaceous Carcinoma","longName":"3248527","preferredDefinition":"An adenocarcinoma with sebaceous differentiation. It presents as a painless mass and it may be multifocal. It grows in the ocular adnexae and in the skin of head and neck, trunk, genitals, and extremities. It is characterized by the presence of malignant cells with multivesicular and clear cytoplasm. It may recur and metastasize.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sebaceous Carcinoma","conceptCode":"C40310","definition":"An adenocarcinoma with sebaceous differentiation. It presents as a painless mass and it may be multifocal. It grows in the ocular adnexae and in the skin of head and neck, trunk, genitals, and extremities. It is characterized by the presence of malignant cells with multivesicular and clear cytoplasm. It may recur and metastasize.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-B927-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"375CBC91-9457-3C74-E050-BB89AD4344B9","beginDate":"2016-07-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-07-11","modifiedBy":"ONEDATA","dateModified":"2016-07-11","deletedIndicator":"No"},{"value":"Neuroendocrine carcinoma","valueDescription":"Neuroendocrine Carcinoma","ValueMeaning":{"publicId":"5340871","version":"1","preferredName":"Neuroendocrine Carcinoma","longName":"5340871","preferredDefinition":"A malignant neuroendocrine neoplasm composed of cells containing secretory granules that stain positive for NSE and chromogranin.  The neoplastic cells are often round and form clusters or trabecular sheets.  Representative examples are small cell carcinoma, large cell neuroendocrine carcinoma, and Merkel cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuroendocrine Carcinoma","conceptCode":"C3773","definition":"A usually aggressive carcinoma composed of malignant cells exhibiting neuroendocrine differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"375CBC91-9462-3C74-E050-BB89AD4344B9","latestVersionIndicator":"Yes","beginDate":"2016-07-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-07-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"375CBC91-947A-3C74-E050-BB89AD4344B9","beginDate":"2016-07-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-07-11","modifiedBy":"ONEDATA","dateModified":"2016-07-11","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"375CBC91-9485-3C74-E050-BB89AD4344B9","beginDate":"2016-07-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-07-11","modifiedBy":"ONEDATA","dateModified":"2016-07-11","deletedIndicator":"No"},{"value":"Glycogen-rich, clear cell carcinoma","valueDescription":"Glycogen-Rich, Clear Cell Breast Carcinoma","ValueMeaning":{"publicId":"5340876","version":"1","preferredName":"Glycogen-Rich, Clear Cell Breast Carcinoma","longName":"5340876","preferredDefinition":"An uncommon, usually aggressive adenocarcinoma of the breast characterized by the presence of clear cells that contain glycogen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glycogen-Rich, Clear Cell Breast Carcinoma","conceptCode":"C40368","definition":"An uncommon, usually aggressive adenocarcinoma of the breast characterized by the presence of clear cells that contain glycogen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"375CD547-5930-BFE6-E050-BB89AD436459","latestVersionIndicator":"Yes","beginDate":"2016-07-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-07-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"375CD547-5949-BFE6-E050-BB89AD436459","beginDate":"2016-07-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-07-11","modifiedBy":"ONEDATA","dateModified":"2016-07-11","deletedIndicator":"No"},{"value":"Oncocytic carcinoma","valueDescription":"Oncocytic Breast Carcinoma","ValueMeaning":{"publicId":"5340877","version":"1","preferredName":"Oncocytic Breast Carcinoma","longName":"5340877","preferredDefinition":"A rare breast adenocarcinoma characterized by the presence of neoplastic oncocytic cells.  The oncocytic cells comprise more than 70 percent of the malignant cellular population.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Oncocytic Carcinoma","conceptCode":"C40366","definition":"A rare breast adenocarcinoma characterized by the presence of malignant oncocytic cells. The oncocytic cells comprise more than 70 percent of the malignant cellular population.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"375CD547-5955-BFE6-E050-BB89AD436459","latestVersionIndicator":"Yes","beginDate":"2016-07-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-07-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"375CD547-596E-BFE6-E050-BB89AD436459","beginDate":"2016-07-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-07-11","modifiedBy":"ONEDATA","dateModified":"2016-07-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433877","version":"1","preferredName":"Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4D2F-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-72E7-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"COOPERM","dateModified":"2017-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3021954","version":"1","longName":"Caris Life Sciences","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3060675","version":"1","longName":"Biospecimen Repository","context":"NCIP"},{"publicId":"10000006","version":"1","longName":"Breast","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Index Biopsy Findings","type":"Preferred Question Text","description":"Index Biopsy Findings","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-797C-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"MAESKEB","dateModified":"2013-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}